liver cirrhosis

05/05/2014 - 11:16

Liver cancer survival rates could be improved if more people with cirrhosis are screened for tumors using inexpensive ultrasound scans and blood tests, according to a review by doctors at UT Southwestern Medical Center. The meta-analysis of 47 studies involving more than 15,000 patients found that the three-year survival rate was much higher among patients who received liver cancer screening— 51 percent for patients who were screened compared to 28 percent of unscreened patients. The review also found that cirrhosis patients who were screened for liver cancer were more likely to receive curative treatment rather than palliative, or end-of-life, care.

 

04/04/2014 - 08:31

Drinking two cups of coffee per day substantially reduces risk of death from non-viral hepatitis related liver cirrhosis. This is the main finding of a study from researchers in the USA and Singapore as part of The Singapore Chinese Health Study. The study is published in the journal Hepatology.

 

03/01/2012 - 10:40

Italian and Swiss researchers confirm that induced hyperammonaemia significantly increases daytime sleepiness in patients with cirrhosis. The findings available in the March issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases, show that higher blood levels of ammonia reduced the ability of cirrhotic patients to produce restorative sleep.

02/29/2012 - 10:23

Researchers from the Mayo Clinic confirm that ultrasound-based transient elastography (TE) provides excellent diagnostic accuracy for detecting cirrhosis due to recurrent infection with hepatitis C virus (HCV) infection following liver transplantation. Findings from the study published in the March issue of Liver Transplantation, a journal of the American Association for the Study of Liver Diseases, suggest that detection of significant fibrosis is more accurate when comparing patients with chronic HCV of the native liver.

02/03/2012 - 11:48

Researchers from UCLA's Jonsson Comprehensive Cancer Center have identified a cell-permeable peptide that inhibits a hepatitis C virus protein and blocks the viral replication that can lead to liver cancer and cirrhosis.

03/13/2011 - 00:00

Study finds 15 new genetic signposts for primary biliary cirrhosis. Researchers have provided new clues into the genetics underlying a chronic form of liver disease, called primary biliary cirrhosis,